A move from the over-the-counter exchange to a major U.S. exchange may be coming for this trio of pot stocks.
News & Analysis: Charlotte's Web
The CBD stock nearly recovered all the lost ground from Tuesday's big decline.
An ebbing tide lowers all boats.
No news was bad news for the hemp CBD market leader.
Investors appear to be worried that the company's growth could be stymied by the FDA's sluggishness in establishing CBD regulations.
Shares of this CBD pioneer are falling as a result of Q2 revenue and earnings misses.